Abstract
Polymyositis (PM) is an inflammatory myopathy characterized by symmetric proximal muscle weakness with CD8+ T cells invading non-necrotic muscle fibers. Myositis-specific antibodies may serve as markers of clinical phenotype and treatment response. Statin use has been associated with precipitating an immune-mediated, necrotizing myositis. Herein, we present two cases that were challenging in diagnosis, treatment, and follow-up.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971–82.
Gunawardena H, Betteridge Z, McHugh N. Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol. 2008;20:675–80.
Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006;8:196–203.
Chiu YE, Co DO. Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. Pediatr Dermatol. 2011;28:357–67.
Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient groups. Medicine (Baltimore). 1991;70:360–74.
Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis, and sporadic inclusion body myositis. Curr Opin Neurol. 1996;9:235–9.
Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis. 1990;68:141–57.
Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casiola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63:713–21.
Joy TR, Hegele R. Narrative review: statin-related myopathy. Ann Intern Med. 2009;150:858–68.
Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol. 2011;23:612–9.
Jacobson TA. Toward “pain-free” statin prescribing; clinical algorithm for diagnosis and management of myalgia. Mayo Clin Proc. 2008;83:687–700.
Sirvent P, Mercier J, Lacampagne A. New insights into mechanism of statin-associated myotoxicity. Curr Opin Pharmacol. 2008;8:333–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Thanarajasingam, U., Ernste, F. (2013). Polymyositis. In: Mahmoudi, M. (eds) Challenging Cases in Rheumatology and Diseases of the Immune System. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5088-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5088-7_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5087-0
Online ISBN: 978-1-4614-5088-7
eBook Packages: MedicineMedicine (R0)